Alvotech S.A [ALVO] vs Zoetis [ZTS] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Alvotech S.A wins in 5 metrics, Zoetis wins in 13 metrics, with 0 ties. Zoetis appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricAlvotech S.AZoetisBetter
P/E Ratio (TTM)36.1725.16Zoetis
Price-to-Book RatioN/A13.06N/A
Debt-to-Equity Ratio-7.32137.01Alvotech S.A
PEG Ratio41.601.44Zoetis
EV/EBITDA49.5517.80Zoetis
Profit Margin (TTM)11.26%27.83%Zoetis
Operating Margin (TTM)10.42%40.20%Zoetis
EBITDA Margin (TTM)10.42%40.20%Zoetis
Return on Equity56.17%52.77%Alvotech S.A
Return on Assets (TTM)2.83%15.37%Zoetis
Free Cash Flow (TTM)$-293.84M$2.30BZoetis
Dividend YieldN/A1.11%N/A
1-Year Return-31.08%-22.95%Zoetis
Price-to-Sales Ratio (TTM)4.616.91Alvotech S.A
Enterprise Value$3.71B$70.26BZoetis
EV/Revenue Ratio6.597.49Alvotech S.A
Gross Profit Margin (TTM)57.39%73.62%Zoetis
Revenue per Share (TTM)$2$21Zoetis
Earnings per Share (Diluted)$0.23$5.82Zoetis
Beta (Stock Volatility)0.100.90Alvotech S.A
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Alvotech S.A vs Zoetis Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Alvotech S.A3.13%2.14%5.15%-4.88%3.13%-34.80%
Zoetis1.51%2.03%-3.94%-8.02%-8.26%-9.96%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Alvotech S.A-31.08%26.55%-11.55%-11.55%-11.55%-11.55%
Zoetis-22.95%-0.64%-11.49%242.10%372.17%372.17%

News Based Sentiment: Alvotech S.A vs Zoetis

Alvotech S.A

News based Sentiment: MIXED

Alvotech reported strong revenue growth in H1 2025, but this was coupled with a decline in license revenue and negative analyst sentiment. The company also completed strategic acquisitions and financing, creating a mixed picture for investors. The combination of positive and negative developments warrants a 'mixed' sentiment and a relatively high importance score.

View Alvotech S.A News Sentiment Analysis

Zoetis

News based Sentiment: MIXED

The month featured both positive developments – the CVMP opinion for Portela® and generally positive analyst estimates – alongside negative signals like stock decline, technical warnings, and mixed institutional activity. This creates a balanced, rather than decisively positive or negative, investment narrative.

View Zoetis News Sentiment Analysis

Performance & Financial Health Analysis: Alvotech S.A vs Zoetis

MetricALVOZTS
Market Information
Market Cap i$2.59B$65.09B
Market Cap CategoryMid capLarge cap
10 Day Avg. Volume i468,0103,169,830
90 Day Avg. Volume i360,7202,720,843
Last Close$8.58$167.10
52 Week Range$7.35 - $13.70$139.70 - $200.33
% from 52W High-37.37%-16.59%
All-Time High$18.00 (Feb 26, 2024)$249.27 (Dec 27, 2021)
% from All-Time High-52.33%-32.96%
Growth Metrics
Quarterly Revenue Growth-0.13%0.04%
Quarterly Earnings Growth-0.51%0.15%
Financial Health
Profit Margin (TTM) i0.11%0.28%
Operating Margin (TTM) i0.10%0.40%
Return on Equity (TTM) i0.56%0.53%
Debt to Equity (MRQ) i-7.32137.01
Cash & Liquidity
Book Value per Share (MRQ)$-0.56$11.21
Cash per Share (MRQ)$0.49$3.28
Operating Cash Flow (TTM) i$-42,552,000$2.93B
Levered Free Cash Flow (TTM) i$-164,666,496$2.29B
Dividends
Last 12-Month Dividend Yield iN/A1.11%
Last 12-Month Dividend iN/A$1.86

Valuation & Enterprise Metrics Analysis: Alvotech S.A vs Zoetis

MetricALVOZTS
Price Ratios
P/E Ratio (TTM) i36.1725.16
Forward P/E i41.6023.09
PEG Ratio i41.601.44
Price to Sales (TTM) i4.616.91
Price to Book (MRQ) iN/A13.06
Market Capitalization
Market Capitalization i$2.59B$65.09B
Enterprise Value i$3.71B$70.26B
Enterprise Value Metrics
Enterprise to Revenue i6.597.49
Enterprise to EBITDA i49.5517.80
Risk & Other Metrics
Beta i0.100.90
Book Value per Share (MRQ) i$-0.56$11.21

Financial Statements Comparison: Alvotech S.A vs Zoetis

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)ALVOZTS
Revenue/Sales i$173.24M$2.22B
Cost of Goods Sold i$73.83M$622.00M
Gross Profit i$99.41M$1.60B
Research & Development i$54.72M$157.00M
Operating Income (EBIT) i$18.06M$846.00M
EBITDA i$-101.21M$991.00M
Pre-Tax Income i$9.31M$810.00M
Income Tax i$-22.73M$179.00M
Net Income (Profit) i$32.04M$631.00M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)ALVOZTS
Cash & Equivalents i$38.54M$1.72B
Total Current Assets i$458.87M$5.88B
Total Current Liabilities i$265.81M$3.39B
Long-Term Debt i$1.18B$5.40B
Total Shareholders Equity i$-302.29M$4.66B
Retained Earnings i$-2.33B$12.38B
Property, Plant & Equipment i$422.91M$6.36B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)ALVOZTS
Operating Cash Flow i$4.96M$567.00M
Capital Expenditures i$-23.19MN/A
Free Cash Flow i$-10.82M$438.00M
Debt Repayment i$-5.84MN/A
Common Stock Repurchase iN/A$-443.00M

Short Interest & Institutional Ownership Analysis

MetricALVOZTS
Shares Short i1.47M9.19M
Short Ratio i3.643.71
Short % of Float i0.01%0.02%
Average Daily Volume (10 Day) i468,0103,169,830
Average Daily Volume (90 Day) i360,7202,720,843
Shares Outstanding i301.81M448.47M
Float Shares i117.06M442.31M
% Held by Insiders i0.62%0.00%
% Held by Institutions i0.06%0.99%

Dividend Analysis & Yield Comparison: Alvotech S.A vs Zoetis

MetricALVOZTS
Last 12-Month Dividend iN/A$1.86
Last 12-Month Dividend Yield iN/A1.11%
3-Year Avg Annual Dividend iN/A$1.63
3-Year Avg Dividend Yield iN/A0.24%
3-Year Total Dividends iN/A$4.90
Ex-Dividend DateN/AApr 21, 2025